C12Y 301/21005
Type iii site-specific deoxyribonuclease
Official title: Type III site-specific deoxyribonuclease (3.1.21.5)
C12Y301/21005 (Type iii site-specific deoxyribonuclease) appears on 3 US grants and 3 published applications in this corpus.
Search patents in C12Y- Granted patents
- 3
- Published applications
- 3
- Assignees
- 2
- Inventors
- 7
- Latest grant
- 6 Aug 2019
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2011 | 0 | 1 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 1 | 0 |
| 2015 | 0 | 1 |
| 2016 | 1 | 0 |
| 2017 | 0 | 1 |
| 2018 | 0 | 0 |
| 2019 | 1 | 0 |
By publication year.
Recent patents
- Method for detecting guanine-abasic site in DNA6 Aug 2019US 10,370,703 B2National Institute of Advanced Industrial Science and Technology
- Treatment of disease conditions via administration of DNA repair enzyme2 Aug 2016US 9,404,102 B2University of South Alabama
- Treatment of disease conditions via administration of DNA repair enzyme21 Oct 2014US 8,865,160 B2University of South Alabama
- Method for detecting guanine-abasic site in dna30 Mar 2017US 2017/0088884 A1National Institute of Advanced Industrial Science and Technology
- Treatment of disease conditions via administration of dna repair enzyme30 Apr 2015US 2015/0118217 A1University of South Alabama
- Treatment of disease conditions via administration of dna repair enzyme12 May 2011US 2011/0110908 A1University of South Alabama
Most cited
By later US patents